Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Untethered Microgrippers Sample Biologic Tissue

By BiotechDaily International staff writers
Posted on 13 May 2013
Image: A single μ-gripper next to a catheter (Photo courtesy of Johns Hopkins University).
Image: A single μ-gripper next to a catheter (Photo courtesy of Johns Hopkins University).
A new study describes thermally activated microgrippers that can reach narrow conduits in the body and be used to excise tissue for diagnostic analyses and biopsies.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) designed the submillimeter endoscopic microgrippers (μ-grippers) to resemble biological appendages, such as hands, with rigid phalanges and flexible joints. The residual stress powered actuators allow them to close and grasp without the need for tethers, while the rigid phalanges of the μ-grippers are composed of nickel, and hence, respond to an applied magnetic field. A thermo-sensitive polymer trigger layer on the joints keeps the μ-grippers flat at 4 °C, but softens at 37 °C, causing the μ-grippers to close.

The μ-grippers are small enough that hundreds can be deployed at a time and actuated en masse, and could therefore form the basis for a more statistically efficient means to screen large surface area organs such as the colon. To test the feasibility of biologic tissue sampling with μ-grippers, the researchers used a swine colon in ex vivo studies. They uniformly spread hundreds of μ-grippers by rotating the endoscope during the deployment. The arms of each millimeter-long μ-gripper is composed of chromium and gold actuators that naturally want to bend inwards, but are held back by the thin layer of polymer coating.

To simulate the normal human temperature, the colon was submerged in a water bath kept at 37 °C, whereupon the coating dissolved and the talons snatched up cells at close proximity; the researchers then visually verified the closure of the μ-grippers using endoscopic imaging. After closure, the vast majority of μ-grippers were retrieved using a magnetic catheter inserted through the endoscope. The researchers found that the μ-grippers identified the lesion 45% of the time; when the swarm was boosted up to 1,500 μ-grippers, the efficiency rose to 95%. The study was published in the April 2013 issue of Gastroenterology.

“Our results suggest a new paradigm in medicine whereby large numbers of small, tether-free microsurgical tools could complement individual, large, tethered biopsying devices,” concluded lead author Evin Gultepe, PhD, and colleagues of the department of chemical and biomolecular engineering. “The tissue retrieved by the μ-grippers is of sufficient quality and quantity to allow DNA and RNA extraction, as well as polymerase chain reaction (PCR) amplification in an effort to look for previously identified disease-diagnostic markers.”

Related Links:

Johns Hopkins University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel

New Program Encourages Wide Distribution of Genomic Data

A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser. The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases... Read more

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.